U.S. Luxury Stock News

Gray Media, Inc.'s ( NYSE:GTN ) stock was strong despite it releasing a soft earnings report last week. However, we...

AdvanSix Inc.'s ( NYSE:ASIX ) stock didn't jump after it announced some healthy earnings. Our analysis showed that...

We'd be surprised if Matrix Service Company ( NASDAQ:MTRX ) shareholders haven't noticed that the President of...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Some Lemonade, Inc. ( NYSE:LMND ) shareholders may be a little concerned to see that the CFO, Principal Accounting...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Investors were disappointed with Flotek Industries, Inc.'s ( NYSE:FTK ) earnings, despite the strong profit numbers. We...

Prairie Operating (PROP) shares slipped around 1% Tuesday, continuing a longer slide that has seen the stock decline over the past month and past three months. Investors are keeping an eye on recent trading trends and business fundamentals as the company navigates a changing energy market. See our latest analysis for Prairie Operating. Prairie Operating's share price has struggled to reverse recent declines, with momentum fading after a challenging year. The stock’s year-to-date share price...

Smurfit Westrock Plc's ( NYSE:SW ) earnings announcement last week was disappointing for investors, despite the decent...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

We'd be surprised if Granite Point Mortgage Trust Inc. ( NYSE:GPMT ) shareholders haven't noticed that the Independent...

Jumia Technologies AG ( NYSE:JMIA ) shareholders are probably feeling a little disappointed, since its shares fell 2.6...

Whilst it may not be a huge deal, we thought it was good to see that the Medalist Diversified REIT, Inc. ( NASDAQ:MDRR...

Voyager Therapeutics, Inc. ( NASDAQ:VYGR ) shares have retraced a considerable 26% in the last month, reversing a fair...

Investors who take an interest in Arq, Inc. ( NASDAQ:ARQ ) should definitely note that the CEO, President & Director...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Quantum-Si's significant retail investors ownership suggests that the key decisions are influenced by...

Earlier this month, Cytek Biosciences reported third-quarter 2025 earnings, showing revenue of US$52.29 million and a net loss of US$5.48 million compared to net income in the prior year, and reaffirmed its full-year revenue guidance of US$196 million to US$205 million. This combination of improved quarterly revenue but a swing to quarterly and year-to-date losses provided investors with contrasting signals about Cytek’s ongoing financial health and outlook. We’ll review how the...

Autolus Therapeutics (AUTL) just released its latest quarterly earnings and is drawing increased investor attention thanks to several key developments. The company continues to expand commercial access for Obe-cel, reports strong manufacturing results, and anticipates new data at the upcoming ASH conference. See our latest analysis for Autolus Therapeutics. Autolus Therapeutics has seen a burst of activity lately, from broadening commercial access and updating its leadership team to advancing...

Legence (LGN) shares have moved higher recently, catching investors’ attention after the company reported a strong annual net income improvement and steady revenue growth. The stock is up more than 20% over the past month. See our latest analysis for Legence. Legence’s 1-month share price return of 20.2% is grabbing attention, especially after its annual profit surge. Momentum appears to be building as confidence returns and investors increasingly factor in the company’s growth story. With...

Anavex Life Sciences (AVXL) reported that its lead drug candidate, blarcamesine, for early Alzheimer's disease faced a negative trend vote from the European Medicines Agency's CHMP. This outcome has sparked new questions about regulatory pathways and next steps for the company. See our latest analysis for Anavex Life Sciences. Anavex’s regulatory news contributed to a dramatic shift in sentiment, with the stock’s 1-day share price return tumbling 35.94% and momentum clearly fading. Despite...

On November 13, 2025, Endava and Paysafe announced a multi-year partnership to accelerate smarter payments and community engagement, alongside Paysafe's updated earnings guidance and expanded share buyback authorization following the release of wider quarterly net losses and an increase in buyback plan terms. The coordinated focus on technology-driven payments and increased buyback authorization underscores ongoing efforts by Paysafe to enhance operational resilience, signal management...

Gambling.com Group recently reported its third-quarter 2025 financial results, with sales of US$38.98 million, marking an increase from a year ago, but also posted a net loss of US$3.86 million and updated its full-year revenue outlook to around US$165 million due to ongoing search marketing challenges. A standout insight from the announcement is that sports data services revenue grew very rapidly, now contributing roughly a quarter of total revenue and forming a central part of the...

Titan America (TTAM) shares have moved lower recently, with a drop of nearly 2% at the latest close. Investors are watching to see how the company’s fundamentals might influence its valuation in the current environment. See our latest analysis for Titan America. After a mild pullback in the share price this week, Titan America’s short-term momentum has softened, even after a 3.5% climb over the past month. Looking at the bigger picture, however, the stock’s performance remains cautious for...